Evgeniia N. Bykonia

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

Artem P. Tkachuk, Evgeniia N. Bykonia, Liubov I. Popova et al. · Vaccines · 2020 · 67 citations · Full text

A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels

Denis A. Kleymenov, Evgeniia N. Bykonia, Liubov I. Popova et al. · Frontiers in Immunology · 2021 · 33 citations · Full text

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A

Eugenia A. Panova, Denis A. Kleymenov, Dmitry V. Shcheblyakov et al. · Frontiers in Immunology · 2023 · 28 citations · Full text

One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow

Inna V. Dolzhikova, Vladimir А. Gushchin, Dmitry V. Shcheblyakov et al. · 2021 · 17 citations · Full text

Immunology, Delta Variant, Immunotherapy +16

Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation

Ilya А. Potemkin, Vera S. Kichatova, Е. Yu. Malinnikova et al. · Viruses · 2022 · 14 citations · Full text

Vaccination, Hepatitis D, Hepatitis E Virus +12